APA (7th ed.) Citation

M, L., S, J., J, B., AD, S., TC, H., & JJ, X. (2020). Evaluation of in vitro absorption, distribution, metabolism, and excretion and assessment of drug-drug interaction of rucaparib, an orally potent poly(ADP-ribose) polymerase inhibitor. Xenobiotica; the fate of foreign compounds in biological systems, 50(9), 1032. https://doi.org/10.1080/00498254.2020.1737759

Chicago Style (17th ed.) Citation

M, Liao, Jaw-Tsai S, Beltman J, Simmons AD, Harding TC, and Xiao JJ. "Evaluation of In vitro Absorption, Distribution, Metabolism, and Excretion and Assessment of Drug-drug Interaction of Rucaparib, an Orally Potent Poly(ADP-ribose) Polymerase Inhibitor." Xenobiotica; the Fate of Foreign Compounds in Biological Systems 50, no. 9 (2020): 1032. https://doi.org/10.1080/00498254.2020.1737759.

MLA (9th ed.) Citation

M, Liao, et al. "Evaluation of In vitro Absorption, Distribution, Metabolism, and Excretion and Assessment of Drug-drug Interaction of Rucaparib, an Orally Potent Poly(ADP-ribose) Polymerase Inhibitor." Xenobiotica; the Fate of Foreign Compounds in Biological Systems, vol. 50, no. 9, 2020, p. 1032, https://doi.org/10.1080/00498254.2020.1737759.